Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

14.86
+1.249.10%
Post-market: 14.74-0.1200-0.81%19:05 EST
Volume:3.07M
Turnover:44.09M
Market Cap:751.12M
PE:-3.77
High:14.97
Open:13.48
Low:13.32
Close:13.62
52wk High:17.28
52wk Low:7.30
Shares:50.55M
Float Shares:27.81M
Volume Ratio:1.57
T/O Rate:11.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9460
EPS(LYR):-3.6945
ROE:-190.18%
ROA:-60.98%
PB:18.41
PE(LYR):-4.02

Loading ...

Company Profile

Company Name:
Kalvista Pharmaceuticals Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
270
Office Location:
55 Cambridge Parkway,Suite 901 East,Cambridge,Massachusetts,United States
Zip Code:
02142
Fax:
866 553 3269
Introduction:
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Benjamin L. Palleiko
Chief Executive Officer and Director
Brian J. G. Pereira
Director and Chairman
Bethany Sensenig
Director
Edward W. Unkart
Director
Laurence Reid
Director
Nancy Stuart
Director
Patrick Treanor
Director
William Fairey
Director

Shareholders

Name
Position
Benjamin L. Palleiko
Chief Executive Officer and Director
Bilal Arif
Chief Operating Officer
Brian Piekos
Chief Financial Officer
Christopher Yea
Chief Development Officer
Nicole Sweeny
Chief Commercial Officer
Paul K. Audhya
Chief Medical Officer